Dr. Camilo Moncada  is Director of QC at Rockland Immunochemicals, a US Biotech leader in antibody developments. With his team of scientists, Dr. Moncada develops and validates innovative antibody-based research tools.

Flow cytometry (FCM) is an attractive experimental approach, especially when accurate monitoring of cell membrane and intracellular pathway signaling biomarkers is required.

In a technical note compiled by Dr. Moncada on tebu-bio’s initiative, he reviews 5 simple but critical experimental steps in order to design optimal FCM protocols and improve flow cytometry results.